228 related articles for article (PubMed ID: 17433904)
21. Diagnostic algorithm for thrombophilia screening.
Margetic S
Clin Chem Lab Med; 2010 Dec; 48 Suppl 1():S27-39. PubMed ID: 21054193
[TBL] [Abstract][Full Text] [Related]
22. Quality assurance in hemostasis: the perspective from the College of American Pathologists proficiency testing program.
Cunningham MT; Brandt JT; Chandler WL; Eby CS; Hayes TE; Krishnan J; Lefkowitz JB; Olson JD; Stasik CJ; Teruya J; Van Cott EM
Semin Thromb Hemost; 2007 Apr; 33(3):250-8. PubMed ID: 17427059
[TBL] [Abstract][Full Text] [Related]
23. Investigations from external quality assurance programs reveal a high degree of variation in the laboratory identification of coagulation factor inhibitors.
Favaloro EJ; Bonar R; Kershaw G; Duncan E; Sioufi J; Marsden K
Semin Thromb Hemost; 2009 Nov; 35(8):794-805. PubMed ID: 20169516
[TBL] [Abstract][Full Text] [Related]
24. Gamma testing experience with the ACL TOP hemostasis testing system.
Ho DK; Lollo M; Reyes M; Garvey MB
Lab Hematol; 2006; 12(4):217-21. PubMed ID: 17118773
[TBL] [Abstract][Full Text] [Related]
25. External quality assurance of DNA testing for thrombophilia mutations.
Hertzberg M; Neville S; Favaloro E; McDonald D
Am J Clin Pathol; 2005 Feb; 123(2):189-93. PubMed ID: 15842041
[TBL] [Abstract][Full Text] [Related]
26. Clinical multicenter evaluation of a new FXa-based Antithrombin assay.
Merz M; Böhm-Weigert M; Braun S; Cooper PC; Fischer R; Hickey K; Steffan A; Kemkes-Matthes B; Kitchen S
Int J Lab Hematol; 2011 Oct; 33(5):498-506. PubMed ID: 21535419
[TBL] [Abstract][Full Text] [Related]
27. Interference of factor V Leiden on protein S activity: evaluation of a new prothrombin time-based assay.
Tripodi A; Asti D; Chantarangkul V; Biguzzi E; Mannucci PM
Blood Coagul Fibrinolysis; 2007 Sep; 18(6):543-6. PubMed ID: 17762529
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the automated coagulation analyzer Sysmex CA-7000.
Fischer F; Appert-Flory A; Jambou D; Toulon P
Thromb Res; 2006; 117(6):721-9. PubMed ID: 16098565
[TBL] [Abstract][Full Text] [Related]
29. Validation and quality control of protein microarray-based analytical methods.
Kricka LJ; Master SR
Methods Mol Med; 2005; 114():233-55. PubMed ID: 16156108
[TBL] [Abstract][Full Text] [Related]
30. Quantification of coagulation factors and inhibitors. Still a special task.
Marbet GA
Hamostaseologie; 2006 Jan; 26(1):38-41. PubMed ID: 16444320
[TBL] [Abstract][Full Text] [Related]
31. Achieving and maintaining quality in the laboratory.
Hertzberg MS; Mammen J; McCraw A; Nair SC; Srivastava A
Haemophilia; 2006 Jul; 12 Suppl 3():61-7. PubMed ID: 16683998
[TBL] [Abstract][Full Text] [Related]
32. Does thrombophilia testing help in the clinical management of patients?
Middeldorp S; van Hylckama Vlieg A
Br J Haematol; 2008 Nov; 143(3):321-35. PubMed ID: 18710381
[TBL] [Abstract][Full Text] [Related]
33. Filtered plasma as a potential cause of clinical misdiagnosis: inappropriate testing in a haematology laboratory.
Favaloro EJ; Mohammed A; Coombs R; Mehrabani PA
Br J Biomed Sci; 1995 Dec; 52(4):243-8. PubMed ID: 8555777
[TBL] [Abstract][Full Text] [Related]
34. A survey of coagulation laboratory practice in Thailand: the first step to establish a National External Quality Assessment Scheme (NEQAS) for blood coagulation.
Tientadakul P; Opartkiattikul N; Wongtiraporn W
J Med Assoc Thai; 2007 Dec; 90(12):2616-23. PubMed ID: 18386711
[TBL] [Abstract][Full Text] [Related]
35. [Improvement of routine works and quality control in mycobacterial laboratory].
Suzuki K; Higuchi T
Kekkaku; 2007 Mar; 82(3):217-27. PubMed ID: 17444126
[TBL] [Abstract][Full Text] [Related]
36. Quality in molecular biology testing for inherited thrombophilia disorders.
Cooper PC; Goodeve AC; Beauchamp NJ
Semin Thromb Hemost; 2012 Sep; 38(6):600-12. PubMed ID: 22907670
[TBL] [Abstract][Full Text] [Related]
37. Laboratory test utilization in the diagnosis of hypercoagulability.
McKenzie SB; Clare CN; Smith LA; Sang JE
Clin Lab Sci; 2000; 13(4):215-21. PubMed ID: 11586507
[TBL] [Abstract][Full Text] [Related]
38. Newer synthetic peptide substrates in coagulation testing: some practical considerations for automated methods.
Svendsen LG; Fareed J; Walenga JM; Hoppensteadt D
Semin Thromb Hemost; 1983 Oct; 9(4):250-62. PubMed ID: 6658459
[TBL] [Abstract][Full Text] [Related]
39. Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices.
Ganter MT; Hofer CK
Anesth Analg; 2008 May; 106(5):1366-75. PubMed ID: 18420846
[TBL] [Abstract][Full Text] [Related]
40. Assessment of Hereditary Thrombophilia: Performance of Antithrombin (AT) Testing.
Gausman JN; Marlar RA
Methods Mol Biol; 2017; 1646():161-167. PubMed ID: 28804827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
